Oral and Maxillofacial Surgery In-Service Training (OMSITE) Practice Exam

Adenosine is the first-line medication used in the management of atrioventricular nodal reentrant tachycardia (AVNRT) or supraventricular tachycardia (SVT) when vagal maneuvers are ineffective. This is due to its specific mechanism of action, which involves transiently blocking the conduction through the atrioventricular (AV) node. By doing so, adenosine interrupts the reentrant circuit responsible for the tachycardia, often leading to a return to normal sinus rhythm.

Adenosine has a rapid onset, acting within seconds and is short-acting, making it an ideal choice in acute settings like sedation. Administering adenosine intravenously allows for a quick response, which is crucial in managing episodes of tachycardia effectively and safely, particularly in a sedated patient.

Other medications, while effective in the treatment of SVT, are generally considered if adenosine is ineffective or in other management contexts. Beta-blockers and calcium channel blockers are more commonly used for rate control rather than for immediate conversion from SVT. Amiodarone, on the other hand, is typically reserved for more complex arrhythmias or for cases where